Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

RLMD stock hub

Relmada Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

RLMDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

767.8M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

RLMD

In the news

Latest news · RLMD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-94

P25 -106.6P50 -46.9P75 -3.1

ROIC-57.6

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All RLMD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001553643
Company name	Relmada Therapeutics, Inc.
Country	United States
Country code	US
Cusip	75955J402
Employees	17
Employees Change	-3%
Employees Change Percent	-15
Enterprise value	$674.8M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US75955J4022
Last refreshed	2026-05-10
Market cap	$767.8M
Market cap category	Small-Cap
Price	$7.32
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	RLMD
Website	https://www.relmada.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.47%
FCF yield	-5.96%
P/B ratio	6.2x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-57.4M
Net Income Growth Years	3%
Profit Per Employee	$-3.4M
ROA	-50.24
Roa5y	-54.95
ROCE	-64.18
ROE	-94.05
Roe5y	-96.82
ROIC	-57.57

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-3.15%
Cagr1y	2,032.99%
Cagr3y	31.48%
Cagr5y	-27.42%
EPS Growth Quarters	15
EPS Growth Years	4
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$94M
Cash	$93M
Current Assets	$94M
Current Liabilities	$6.4M
Equity	$86.5M
Liabilities	$7.5M
Long Term Assets	$19,500
Long Term Liabilities	$1.1M
Net Cash	$93M
Net Cash By Market Cap	$12.11
Net Cash Growth	107.1%
Net Debt Equity	$-1.08
Tangible Book Value	$86.5M
Tangible Book Value Per Share	$1.18
WACC	6.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.62
Net Working Capital	$-5.5M
Quick ratio	14.46
Working Capital	$87.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-30.89%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-27.38%
1Y total return	2,028.53%
200-day SMA	3.75
3Y total return	127.33%
50-day SMA	6.64
50-day SMA vs 200-day SMA	50over200
5Y total return	-79.86%
All Time High	80
All Time High Change	-90.85%
All Time High Date	2014-10-29
All Time Low	0.24
All Time Low Change	2,944.93%
All Time Low Date	2025-03-03
ATR	0.46
Beta	0.43
Beta1y	-0.63
Beta2y	1.56
Ch YTD	51.55
High	7.5
High52	8
High52 Date	2026-05-06
High52ch	-8.5%
Low	7.21
Low52	0.34
Low52 Date	2025-05-08
Low52ch	2,072.11%
Ma50ch	10.22%
Premarket Change Percent	0.27
Premarket Price	$7.45
Premarket Volume	422
Price vs 200-day SMA	95.04%
RSI	53.37
RSI Monthly	61.24
RSI Weekly	74.94
Sharpe ratio	2.95x
Sortino ratio	7.29
Total Return	-30.89%
Tr YTD	51.55
Tr1m	8.44%
Tr1w	-4.19%
Tr3m	88.66%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	2
Analyst Price Target Top	$15.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.19
Operating Income	$-56.2M
Price target	$12.4
Price Target Change	$69.4
Price Target Change Top	$112

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	90,264,647%
Float Percent	86.06%
Shares Insiders	4.68%
Shares Institutions	44.01%
Shares Out	104,888,223
Shares Qo Q	84.07%
Shares Yo Y	30.89%
Short Float	6.86%
Short Ratio	4.61
Short Shares	5.9

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-61.7M
Average Volume	1,204,107.1x
Bv Per Share	1.18
Ch10y	-27.38
Ch1m	8.44
Ch1w	-4.19
Ch1y	2,028.5
Ch3m	88.66
Ch3y	127.3
Ch5y	-79.86
Ch6m	176.2
Change	-1.48%
Change From Open	-2.14
Close	7.43
Days Gap	0.67
Dollar Volume	6,079,113.6
Earnings Date	2026-05-12
Earnings Time	amc
EBIT	$-56.2M
EPS	$-1.45
F Score	2
FCF	$-45.8M
FCF EV Yield	-6.79x
FCF Per Share	$-0.44
Financing CF	93,564,808
Fiscal Year End	December
Founded	2,004
Investing CF	-48,138,306
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-19
Last Report Date	2025-12-31
Last Split Date	2019-09-30
Last Split Type	Reverse
Last10k Filing Date	2026-03-19
Ma150	4.63
Ma150ch	58.13%
Ma20	7.32
Ma20ch	-0.03%
Net CF	-360,486
Next Earnings Date	2026-05-12
Open	7.48
Optionable	Yes
Position In Range	37.93
Post Close	7.32
Postmarket Change Percent	0.14
Postmarket Price	$7.33
Pre Close	7.43
Price Date	2026-05-08
Ptbv Ratio	8.87
Relative Volume	0.69x
Share Based Comp	15,866,871
Tr6m	176.23%
Us State	Florida
Volume	830,480

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does RLMD pay a dividend?

Capital-return profile for this ticker.

Performance

RLMD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns RLMD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+44.0%

Float: +86.1% of shares outstanding

Insider ownership

+4.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

RLMD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

53.4

Neutral momentum band

Price vs 200-day MA

+95.0%

50/200-day relationship not available

Beta (5Y)

0.43

Less volatile than the market

Sharpe ratio

2.95

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About RLMD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current RLMD stock rating?

Relmada Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full RLMD analysis?

The full report lives at /stocks/RLMD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for RLMD?

The latest report frames RLMD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the RLMD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.